Hui‐Zhi Long
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 3
- Cancer, Lipids, and Metabolism 2
- Biological Psychiatry top 10%
- Neurology top 10%
-
- Ferroptosis and cancer prognosis 6
-
- PI3K/AKT/mTOR signaling in cancer 2
-
- Cancer Mechanisms and Therapy 2
-
- Immune cells in cancer 2
-
- Gastroesophageal reflux and treatments 1
-
- Medicinal Plants and Neuroprotection 1
- Co-authors
- Hongyu LuoLichen GaoZiwei ZhouDan‐Dan WenShuo‐Guo XuFeng‐Jiao LiYan ChengYuting Fu
- Journals
- Frontiers in Microbiology (1 paper)Frontiers in Pharmacology (5 papers)Journal of Pharmacy and Pharmacology (1 paper)
- Partner nations
- China
In The Last Decade
Hui‐Zhi Long
15 papers receiving 900 citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 252
- Biological Psychiatry 35
- Neurology 81
- Pulmonary and Respiratory Medicine 271
- Molecular Biology 499
Countries citing papers authored by Hui‐Zhi Long
This map shows the geographic impact of Hui‐Zhi Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Zhi Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Zhi Long more than expected).
Fields of papers citing papers by Hui‐Zhi Long
This network shows the impact of papers produced by Hui‐Zhi Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Zhi Long. The network helps show where Hui‐Zhi Long may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui‐Zhi Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 52 | |
| 4 | 2023 | 3 | |
| 5 | System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapybreakdown → | 2022 | 272 |
| 6 | 2022 | 3 | |
| 7 | 2022 | 20 | |
| 8 | 2022 | 34 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 20 | |
| 11 | 2022 | 65 | |
| 12 | 2021 | 35 | |
| 13 | PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Diseasebreakdown → | 2021 | 321 |
| 14 | 2021 | 47 | |
| 15 | 2021 | 14 | |
| 16 | 2020 | 11 |
About Hui‐Zhi Long
Hui‐Zhi Long is a scholar working on Pharmacology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 904 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (6 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Mechanisms and Therapy (2 papers), Cancer, Lipids, and Metabolism (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Immune cells in cancer (2 papers), Gastroesophageal reflux and treatments (1 paper) and Medicinal Plants and Neuroprotection (1 paper). The work is most often cited by research in Cancer Research (252 citations), Biological Psychiatry (35 citations) and Neurology (81 citations). Hui‐Zhi Long has collaborated with scholars based in China. Frequent co-authors include Hongyu Luo, Lichen Gao, Ziwei Zhou, Dan‐Dan Wen, Shuo‐Guo Xu, Feng‐Jiao Li, Yan Cheng, Ziwei Zhou, Yan Cheng and Yuting Fu. Their work appears in journals such as Frontiers in Microbiology, Frontiers in Pharmacology and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.